Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM
Clinical trial NCT02227212 · COMPLETED
Trial details
- NCT number
- NCT02227212
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.